(Q61981264)
Statements
A Randomized, Open Label, Two Treatment, Two Period, Two Sequence, Single Dose, Crossover, Bioequivalence Study of SPARC_147709- Test and Reference, 2mg/ml (30 mg/m2 Dose) in Patients With Multiple Myeloma (English)
0 references
November 2010
0 references
January 2011
0 references
24
0 references
18 year
0 references